Pathogenesis of demyelination induced by a mouse hepatitis.
D000818:Animals; D000831:Animals, Newborn; D000914:Antibodies, Viral; D000917:Antibody Formation / Q000187:drug effects; D003520:Cyclophosphamide / Q000627:therapeutic use; D003711:Demyelinating Diseases / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D005455:Fluorescent Antibody Technique; D006520:Hepatitis, Animal / Q000150:complications* / Q000188:drug therapy; D007136:Immunoglobulins; D007165:Immunosuppression Therapy; D051379:Mice; D008854:Microscopy, Electron; D006517:Murine hepatitis virus / Q000276:immunology; D009500:Neutralization Tests; D013116:Spinal Cord / Q000473:pathology; D014779:Virus Replication
D000914:Antibodies, Viral; D007136:Immunoglobulins; D003520:Cyclophosphamide